Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, UK

Background

Cancer risk following long-term exposure to systemic immunomodulatory therapies in psoriasis patients is possible.

Objectives

To assess a dose-response relationship between cumulative length of exposure to biologic therapy and risk of cancer.

Leggi l'articolo completo

I. Garcia - Doval, M.A. Descalzo, K.J. Mason, A.D. Cohen, A.D. Ormerod, F.J. Gómez - García, S. Cazzaniga, I. Feldhamer, H. Ali, E. Herrera - Acosta, C.E.M. Griffiths, R. Stern, L. Naldi, The Psonet Network

https://doi.org/10.1111/bjd.16715